Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. Ann Surg Oncol 2010 Nov;17(11):2803-5
Date
08/26/2010Pubmed ID
20737218DOI
10.1245/s10434-010-1285-8Scopus ID
2-s2.0-78049487062 (requires institutional sign-in at Scopus site) 58 CitationsAuthor List
Evans DB, Erickson BA, Ritch PAuthors
Beth A. Erickson MD Professor in the Radiation Oncology department at Medical College of WisconsinDouglas B. Evans MD Chair, Professor in the Surgery department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdenocarcinomaAntineoplastic Agents
Combined Modality Therapy
Humans
Neoadjuvant Therapy
Neoplasm Invasiveness
Neoplasm Staging
Pancreatic Neoplasms
Radiotherapy, Adjuvant